Delivery Order SPE2DB25D3003-SPE2DB25FPXBE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Doxycycline 50 mg, with a ceiling value of $2,358.72 and an ultimate completion date of September 26, 2025. This award represents a competitive, firm fixed-price delivery order with no set-aside designation, reflecting the agency's selection of AmerisourceBergen based on open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,232.51 for Doxycycline 50 mg tablets (60-count units) on August 21, 2025, with completion scheduled for August 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $10,374.00 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (300 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,248,437 doxycycline 50 mg tablets. The contract, valued at $16,543.56, has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania. This delivery order is placed under an...
- The Defense Logistics Agency awarded a $1,199.28 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This is a firm fixed-price, non-set-aside contract with a completion date of September 11, 2025, and performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's significant role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $101,186.24 to AmerisourceBergen Drug Corp for Doxycycline Hyclate 20 mg tablets in quantities of 90s, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location in the same city. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,736.07 to AmerisourceBergen Drug Corp for the procurement of Doxycycline Hyclate 100 mg tablets (1,000 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This delivery order was issued under a firm fixed price structure with no set-aside designation, awarded through open competition. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. As...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a ceiling value of $3,906.59 and a completion date of September 23, 2025. This non-set-aside contract reflects a firm fixed price arrangement for pharmaceutical delivery to support federal medical supply needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for the supply of Doxycycline Hyclate 20 mg tablets (90-count) with a ceiling value of $5,601.60. The award, made on September 23, 2025, is a firm fixed price contract with an ultimate completion date of September 24, 2025, and carries no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,099.86 to AmerisourceBergen Drug Corp for the supply of Doxycycline 50 mg tablets (60-count packages) with an ultimate completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPXBEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Doxycycline 50 mg tablets (60-count units) with a ceiling value of $13,880.36. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 29, 2025. The award was issued on August 28, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contracting demonstrates its critical role as a vendor for military and veteran healthcare systems, with delivery orders spanning diverse therapeutic domains and price points, reflecting the company's capacity to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 8/28/25 |